Clinical Trials
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0408
A Phase II Trial of Neoadjuvant Capecitabine, Oxaliplatin and Bevacizumab for Resectable Colorectal Metastases in the Liver
Research Committee(s)
Gastrointestinal Cancer
Activated
11-15-2006
Closed
04-01-2007
Closed
Phase
Accrual
9%
SWOG Clinical Trial Number
S0425
Neoadjuvant Chemoradiation Therapy with Oxaliplatin and Capecitabine for Patients with Surgically Resectable Gastric Cancer: A Pilot Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-2006
Closed
01-15-2008
Closed
Phase
Accrual
72%
Published
SWOG Clinical Trial Number
S0514
Phase II Study of BAY 43-9006 (NSC #724772) as Single Agent in Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
10-01-2005
Closed
01-01-2007
Closed
Phase
Accrual
29%
Published
SWOG Clinical Trial Number
S0414
Cetuximab Plus Cisplatin, Irinotecan and Thoracic Radiotherapy (TRT) for Locally Advanced (Non-Metastatic), Clinically Unresectable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
05-01-2005
Closed
09-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0413
Phase II Study of GW572016 (NSC #727989) as First Line Therapy in Patients with Advanced or Metastatic Gastric Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
12-15-2004
Closed
05-15-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0415
Cetuximab as a Second Line Therapy in Patients with Metastatic Esophageal Cancer - Phase II
Activated
10-15-2004
Closed
01-01-2007
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0356
Oxaliplatin Plus Protracted Infusion 5-Fluorouracil and Radiation for Potentially Curable Esophageal Cancer: A Phase II Trial with Molecular Correlates
Research Committee(s)
Gastrointestinal Cancer
Activated
09-15-2004
Closed
08-01-2008
Closed
Phase
Accrual
0%
SWOG Clinical Trial Number
S0304
A Phase II Feasibility Translational Research Trial of Induction Chemotherapy Followed by Concomitant Chemoradiation in Patients with Clinical T3-T4 Rectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
08-01-2004
Closed
02-01-2006
Closed
Phase
Accrual
70%
Published
SWOG Clinical Trial Number
S0336
Phase II Trial of Depsipeptide (NSC-630176) in Colorectal Cancer Patients Who Have Received Either One or Two Chemotherapy Regimens for Metastatic or Locally Advanced, Unresectable Disease
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2004
Closed
09-01-2005
Closed
Phase
Accrual
2%
SWOG Clinical Trial Number
S0303
A Phase III Trial of Modified FOLFOX6 versus CAPOX, with Bevacizumab (NSC-704865) or Placebo*, as First-Line Therapy in Patients with Previously Untreated Advanced Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-01-2004
Closed
09-01-2004
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0205
A Phase III Randomized Open-Label Study Comparing Gemcitabine Plus Cetuximab (IMC-C225) Versus Gemcitabine as First-Line Therapy of Patients with Advanced Pancreas Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
01-01-2004
Closed
04-01-2006
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0202
A Phase II Trial of Gemcitabine (NSC-613327) and Capecitabine (NSC-712807) in Patients with Unresectable or Metastatic Gallbladder or Cholangiocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
09-01-2003
Closed
04-01-2005
Closed
Phase
Accrual
48%
Published
SWOG Clinical Trial Number
S0030
Protocol for Assessment of Capecitabine for Advanced Colorectal Cancer in Patients Aged 70 Years and Older (and in a Cohort of Patients Younger than 60 Years)
Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-2003
Closed
02-01-2005
Closed
Phase
Accrual
88%
Published
SWOG Clinical Trial Number
S0127
A Phase II Study of OSI-774 (NSC #718781) in Unresectable or Metastatic Adenocarcinoma of the Stomach and Gastroesophageal Junction
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2002
Closed
08-15-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0107
A Phase II Trial of Epothilone B Analogue BMS-247550 (NSC #710428) Every 21 Days in Patients With Advanced Pancreas Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
07-01-2001
Closed
06-01-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S0101
A Phase II Study of Gemcitabine Plus Irinotecan (CPT-11) In Patients With Esophageal Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-2001
Closed
02-01-2003
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9915
A Phase II Study of PN401, 5-FU, and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach.
Research Committee(s)
Gastrointestinal Cancer
Activated
02-15-2001
Closed
09-01-2002
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
S9923
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Colorectal Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
08-01-2001
Closed
Phase
Accrual
97%
Published
SWOG Clinical Trial Number
S9924
A Phase II Trial of R115777 (NSC #70818) in Patients with Advanced Pancreas Cancer.
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-2000
Closed
06-01-2001
Closed
Phase
Accrual
49%
Published
SWOG Clinical Trial Number
S9635
A Phase II Trial of 5-fluorouracil Plus 776C85 in Patients With Advanced Resistant Colorectal Cancer
Research Committee(s)
Gastrointestinal Cancer
Activated
04-01-1998
Closed
09-15-2000